Viracta(VIRX) - 2019 Q4 - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (SNSS) Q4 2019 Results Earnings Conference Call March 10, 2020 4:30 PM ET Company Participants Willie Quinn - Chief Financial Officer, Senior Vice President, Finance and Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer, Executive Vice President, Research & Development Conference Call Participants Hartaj Singh - Oppenheimer Jim Birchenough - Wells Fargo Marc Frahm - Cowen Operator Welcome to Sunesis Pharmaceuticals fourt ...